Patent · US Active

Formulations for drug-coated medical devices

US9974888B2 · kind B2 · utility

0Cited by

6References

10Claims

0Family size

Assignee

INNORA GMBH · DE

Inventors

Ulrich Speck · Berlin, DE
Madeleine Caroline Berg · Berlin, DE

Key dates

Filing date	Nov 3, 2010
Grant date	May 22, 2018
Priority date	—
Expiry date	Nov 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/416
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.